BioHarvest Sciences Inc. Signs an Exclusive Agreement with Cukierman & Co. Life Sciences to Explore Pharmaceutical Partnerships for the Use of VINIA as an Adjuvant Therapy in Type 2 Diabetes Treatments Biotech Investing
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020 Biotech Investing
Bristol Myers Squibb Announces Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion Biotech Investing
Amgen Sponsors Golden Ticket at BioLabs LA at The Lundquist Institute to Help Accelerate Life Science Startups Biotech Investing
Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD Biotech Investing
Bristol Myers Squibb and The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19 Biotech Investing
